Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Rijken

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Thrombosis and Haemostasis|October 31, 1984
Masking of fibrinolytic response to stimulation by an inhibitor of tissue-type plasminogen activator in plasmaE J Brommer, J H Verheijen, G T Chang, et al.
Klinische Wochenschrift|January 1, 1988
[Recombinant tissue-type plasminogen activator: pharmacokinetics and effect on the hemostasis system of the human]E Seifried, F Böck, P Tanswell, et al.
The Journal of Biological Chemistry|January 25, 1992
In vivo and in vitro interaction of high and low molecular weight single-chain urokinase-type plasminogen activator with rat liver cellsJ Kuiper, D C Rijken, G A de Munk, et al.
The Biochemical Journal|June 1, 1992
Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PAM Otter, J Kuiper, R Bos, et al.
Biochimica Et Biophysica Acta|April 21, 1982
Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cellsK Bykowska, E G Levin, D C Rijken, et al.
Thrombosis and Haemostasis|December 29, 1984
Fibrinolytic activators and inhibitors in terminal renal insufficiency and in anephric patientsE J Brommer, I Schicht, G Wijngaards, et al.
Annals of the Rheumatic Diseases|March 25, 2000
Urokinase-mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombinE A Braat, A F Jie, H K Ronday, et al.
Biochimica Et Biophysica Acta|September 21, 2000
The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cellsE A Braat, A Collen, A F Jie, et al.
Thrombosis and Haemostasis|July 29, 1984
Modulation of rapid plasminogen activator inhibitor in plasma by stanozololJ H Verheijen, D C Rijken, G T Chang, et al.
Biochemical and Biophysical Research Communications|September 26, 2006
Hepatocyte-derived fibrinogen-related protein-1 is associated with the fibrin matrix of a plasma clotD C Rijken, S P G Dirkx, T M Luider, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Thrombosis and Haemostasis|October 31, 1984
Masking of fibrinolytic response to stimulation by an inhibitor of tissue-type plasminogen activator in plasmaE J Brommer, J H Verheijen, G T Chang, et al.
Klinische Wochenschrift|January 1, 1988
[Recombinant tissue-type plasminogen activator: pharmacokinetics and effect on the hemostasis system of the human]E Seifried, F Böck, P Tanswell, et al.
The Journal of Biological Chemistry|January 25, 1992
In vivo and in vitro interaction of high and low molecular weight single-chain urokinase-type plasminogen activator with rat liver cellsJ Kuiper, D C Rijken, G A de Munk, et al.
The Biochemical Journal|June 1, 1992
Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PAM Otter, J Kuiper, R Bos, et al.
Biochimica Et Biophysica Acta|April 21, 1982
Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cellsK Bykowska, E G Levin, D C Rijken, et al.
Thrombosis and Haemostasis|December 29, 1984
Fibrinolytic activators and inhibitors in terminal renal insufficiency and in anephric patientsE J Brommer, I Schicht, G Wijngaards, et al.
Annals of the Rheumatic Diseases|March 25, 2000
Urokinase-mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombinE A Braat, A F Jie, H K Ronday, et al.
Biochimica Et Biophysica Acta|September 21, 2000
The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cellsE A Braat, A Collen, A F Jie, et al.
Thrombosis and Haemostasis|July 29, 1984
Modulation of rapid plasminogen activator inhibitor in plasma by stanozololJ H Verheijen, D C Rijken, G T Chang, et al.
Biochemical and Biophysical Research Communications|September 26, 2006
Hepatocyte-derived fibrinogen-related protein-1 is associated with the fibrin matrix of a plasma clotD C Rijken, S P G Dirkx, T M Luider, et al.
Pageof 11